相关实验视频

Updated: Jun 4, 2025

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

肝移植后癌症相关结果缺乏进展:减轻风险和确定未来需要移动这个针

Alex Liu¹, Wei Rao², Kymberly D Watt^1,3

¹Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA.

Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society

|December 26, 2024

概括

肝移植接受者面临着相当大的癌症风险. 个性化查,改变生活方式和获得新的癌症疗法对于改善这一弱势群体的结果至关重要.

科学领域:

在瘤学瘤学.
移植医学移植医学
免疫学免疫学免疫学

背景情况:

恶性病症显著影响肝移植后的长期存活率.
癌症查和向治疗的进步改善了一般人群的结果,但对移植接受者来说并不显著.
肝移植接受者是高风险人群,需要个性化降低癌症风险的策略.

研究的目的:

审查目前关于肝移植接受者癌症风险,查和管理的数据.
强调需要个性化策略,包括改变生活方式和药物管理.
强调这一群体获得新型抗癌疗法的重要性.

主要方法:

对肝移植接受者的癌症现有数据的文献综述.
对移植种群特有的查和监测协议的评估.
评估免疫抑制和非免疫抑制药物对癌症风险的影响.
审查新兴的抗癌疗法及其对移植接受者的适用性.

主要成果:

癌症风险和结果仍然是肝移植幸存者的关键问题.
目前癌症治疗的进展并没有相应地使移植人口受益.
对查,生活方式和药物管理的个性化方法至关重要.
获得新型免疫疗法和抗癌药物对于改善与癌症相关的结果至关重要.

结论:

针对肝移植接受者进行量身定制的查和监测是必要的.
药物管理,包括免疫抑制剂,需要仔细考虑癌症风险.
促进获得先进的癌症疗法对于改善生存率至关重要.
需要进一步的前性研究来优化免疫抑制策略,以最大限度地提高癌症反应.

更多相关视频

The Influence of Liver Resection on Intrahepatic Tumor Growth

The Influence of Liver Resection on Intrahepatic Tumor Growth

Published on: April 9, 2016

Reduced Complications after Arterial Reconnection in a Rat Model of Orthotopic Liver Transplantation

Reduced Complications after Arterial Reconnection in a Rat Model of Orthotopic Liver Transplantation

Published on: November 7, 2020

相关概念视频

Tissue Transplantation

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...